Carrizzo et al. demonstrated that PTX3 administration in mice causes endothelial dysfunction and increased blood pressure via the P-selectin/MMP1, which then acts through nitric-oxide-mediated signaling pathways [145,146]. Here, PTX3 is linked to endothelial dysfunction.